ライフサイエンスコーパス: cardiac tamponade

1 tion and technical surgical factors, such as cardiac tamponade).

2 with acute myocardial infarction and 1 with cardiac tamponade).

3 rate of blood transfusions or occurrence of cardiac tamponade.

4 ving implants, 4 patients (8.9%) experienced cardiac tamponade.

5 ve US examinations and returned with delayed cardiac tamponade.

6 to a reference standard for the diagnosis of cardiac tamponade.

7 basic diagnostic tests for the diagnosis of cardiac tamponade.

8 r malposition, pneumothorax, hemothorax, and cardiac tamponade.

9 sudden massive hemopericardium resulting in cardiac tamponade.

10 urgical procedures or chest trauma can cause cardiac tamponade.

11 ccurred in only 0.63% of patients, including cardiac tamponade (0.16%), vascular injury requiring int

12 rgical intervention (0.9%), and 1 episode of cardiac tamponade (0.9%) requiring pericardiocentesis.

13 patients (2.7%) experienced complications: 5 cardiac tamponades (1.4%), 4 pseudoaneurysms (1.1%), and

14 es, but adverse events included 1 episode of cardiac tamponade, 1 stroke without residual defect, and

15 TCA was the result of cardiac tamponade (105 patients, 17.5%), exsanguination

16 , the presence of pericardial effusion (1C), cardiac tamponade (1B), valvular dysfunction (1C), endoc

17 ts, 69.6%), and exsanguination combined with cardiac tamponade (72 patients, 12.0%).

18 cause of TCA: 22 of 105 patients (21%) with cardiac tamponade, 8 of 418 patients (1.9%) with exsangu

19 Among patients with cardiac tamponade, a minority will not have dyspnea, tac

20 re no survivors beyond 15 minutes of TCA for cardiac tamponade and 5 minutes after exsanguination.

21 There was a 2% incidence of cardiac tamponade and a 2.5% incidence of phrenic nerve

22 ith Mycoplasma pneumoniae that progressed to cardiac tamponade and constrictive pericarditis.

23 They included one episode of cardiac tamponade and one myocardial infarction in the h

24 remained stable over time, whereas rates of cardiac tamponade and pacemaker implantation significant

25 A case of hemopericardium, cardiac tamponade, and death caused by perforation of th

26 as death, myocardial infarction, stroke, or cardiac tamponade, and feasibility, defined as successfu

27 l bleeding, spontaneous hemopericardium with cardiac tamponade, and hemarthrosis in 11, 7, 1, and 1 p

28 teric ischemia, kidney failure, hypotension, cardiac tamponade, and limb ischemia) were increased in

29 disseminated intravascular coagulopathy, and cardiac tamponade, and the patient died on the fourth ho

30 Key clinical findings in patients with cardiac tamponade are hypotension, increased jugular ven

31 action, nerve injury, arteriovenous fistula, cardiac tamponade, arrhythmia, and delay of >=1 hour in

32 ergoing device implantation procedures, with cardiac tamponade being the most common cause of death.

33 dial temperature, without the development of cardiac tamponade, can be attained using a pericardial c

34 may require emergency pericardiocentesis if cardiac tamponade develops.

35 her adverse events including cardiac arrest, cardiac tamponade, device infection, pneumothorax, and i

36 perform pericardiocentesis in patients with cardiac tamponade diagnosed by echocardiography.

37 One patient (treatment group) had a cardiac tamponade during mapping.

38 developed right ventricular perforation and cardiac tamponade during the implant procedure, and even

39 mplication rate (perforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and

40 No intraprocedural deaths, cardiac tamponade, emergency surgery, stroke, myocardial

41 r the quick identification and management of cardiac tamponade even in procedures typically believed

42 ardial effusion helps distinguish those with cardiac tamponade from those without.

43 Major bleeding was defined as either cardiac tamponade, hematoma that required intervention,

44 Three patients (0.4%) had cardiac tamponade/hemopericardium, and 5 patients (0.7%)

45 ected patients are pericardial effusion with cardiac tamponade, high-grade arrhythmia with sudden car

46 bleeding (HR: 2.01 [95% CI: 0.91 to 4.44]), cardiac tamponade (HR: 2.38 [95% CI: 0.56 to 10.1]), and

47 re-related stroke; there were three cases of cardiac tamponade in the ablation group.

48 of-hospital TCA, particularly when caused by cardiac tamponade, in situations where other treatment o

49 Also in cardiac tamponade-induced nonocclusive intestinal ischem

50 Generally, cardiac tamponade is a clinical diagnosis that can be co

51 Cardiac tamponade is a medical emergency caused by the p

52 Cardiac tamponade is a potentially life-threatening proc

53 Cardiac tamponade is a state of hemodynamic compromise r

54 Cardiac tamponade is preferably resolved by echocardiogr

55 Cardiac tamponade is the most dramatic complication obse

56 Major hemorrhage or cardiac tamponade leading to reoperation occurred in 1.4

57 One other patient experienced cardiac tamponade, leading to termination of the procedu

58 tourinary bleeding; intracranial hemorrhage; cardiac tamponade; nonbypass surgery-related blood trans

59 patients in the placebo group (P=0.75), and cardiac tamponade occurred at rates of 1.1% and 0.4%, re

60 0.67; 95% CI, 0.31-1.43; P=0.30), including cardiac tamponade (OR, 0.69; 95% CI, 0.19-2.47; P=0.57).

61 of cardiac arrest, e.g., pulmonary embolism, cardiac tamponade, or hypovolemia, and signal the return

62 pericardial complications (hemopericardium, cardiac tamponade, or pericardiocentesis), pneumothorax,

63 Cardiac tamponade, permanent pacemaker implantation, maj

64 y efficacy outcome was a composite of death, cardiac tamponade requiring pericardiocentesis, or const

65 ignificant effect on the composite of death, cardiac tamponade requiring pericardiocentesis, or const

66 /82); 1 nonembolic stroke due to exacerbated cardiac tamponade secondary to catheter perforation and

67 sues identified peracute hemopericardium and cardiac tamponade to be the cause.

68 No death, cardiac tamponade, ventricular arrhythmia, or other proc

69 Cardiac tamponade was less common in PCS patients (P=0.0

70 Overall, cardiac tamponade was the most frequent direct cause of

71 es were reported in either group; 4 cases of cardiac tamponade were reported in the ablation group.